Deutsche Bank
CYTK icon

Deutsche Bank’s Cytokinetics CYTK Stock Holding History

Deutsche Bank’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,000
Closed -$3K – 6168
2014
Q3 		$3K Buy
+1,000
New +$4.2K ﹤0.01% 5608

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's CYTK Position: Q2 2026 in Review

Deutsche Bank increased its Cytokinetics (CYTK) stake by 16% in Q2 2026, buying an estimated $2.11M and bringing the position to 216,540 shares worth $18.4M. The position accounts for 0.01% of the portfolio, ranked #879.

Deutsche Bank first reported a position in CYTK in Q3 2013 and has held it in 52 quarters since. The position peaked at $47.2M in Q4 2023. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Deutsche Bank held 216,540 shares of Cytokinetics worth $18.4M as of Q2 2026.
  • Deutsche Bank bought 29,402 Cytokinetics shares in Q2 2026, an estimated $2.11M.
  • Cytokinetics made up 0.01% of Deutsche Bank's portfolio in Q2 2026, its #879 holding.
  • Deutsche Bank first reported a position in Cytokinetics in Q3 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Cytokinetics position peaked at $47.2M in Q4 2023.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.